JP2023527309A5 - - Google Patents

Info

Publication number
JP2023527309A5
JP2023527309A5 JP2022571116A JP2022571116A JP2023527309A5 JP 2023527309 A5 JP2023527309 A5 JP 2023527309A5 JP 2022571116 A JP2022571116 A JP 2022571116A JP 2022571116 A JP2022571116 A JP 2022571116A JP 2023527309 A5 JP2023527309 A5 JP 2023527309A5
Authority
JP
Japan
Prior art keywords
poly
virus
human
methyl
rna polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022571116A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023527309A (ja
Filing date
Publication date
Priority claimed from PCT/US2021/031629 external-priority patent/WO2021226597A2/en
Application filed filed Critical
Priority claimed from PCT/US2021/033276 external-priority patent/WO2021236855A1/en
Publication of JP2023527309A publication Critical patent/JP2023527309A/ja
Publication of JP2023527309A5 publication Critical patent/JP2023527309A5/ja
Pending legal-status Critical Current

Links

JP2022571116A 2020-05-19 2021-05-19 環状rna組成物及び方法 Pending JP2023527309A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063027292P 2020-05-19 2020-05-19
US63/027,292 2020-05-19
USPCT/US2021/031629 2021-05-10
PCT/US2021/031629 WO2021226597A2 (en) 2020-05-08 2021-05-10 Circular rna compositions and methods
PCT/US2021/033276 WO2021236855A1 (en) 2020-05-19 2021-05-19 Circular rna compositions and methods

Publications (2)

Publication Number Publication Date
JP2023527309A JP2023527309A (ja) 2023-06-28
JP2023527309A5 true JP2023527309A5 (cg-RX-API-DMAC7.html) 2024-04-23

Family

ID=76744897

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022571116A Pending JP2023527309A (ja) 2020-05-19 2021-05-19 環状rna組成物及び方法

Country Status (8)

Country Link
US (1) US20240042015A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023527309A (cg-RX-API-DMAC7.html)
CN (1) CN116322788A (cg-RX-API-DMAC7.html)
AU (1) AU2021276410A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022023554A2 (cg-RX-API-DMAC7.html)
CA (1) CA3179423A1 (cg-RX-API-DMAC7.html)
MX (1) MX2022014660A (cg-RX-API-DMAC7.html)
WO (1) WO2021236855A1 (cg-RX-API-DMAC7.html)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112399860B (zh) 2018-06-06 2024-08-16 麻省理工学院 用于在真核细胞中翻译的环状rna
DK3864163T3 (da) 2018-10-09 2024-05-06 Univ British Columbia Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed
WO2021236952A1 (en) * 2020-05-20 2021-11-25 Flagship Pioneering, Inc. Compositions and methods for producing human polyclonal antibodies
AU2022234607B2 (en) 2021-03-10 2025-01-23 Rznomics Inc. Self-circularized RNA structure
AU2022332372B2 (en) 2021-08-27 2025-12-04 Peking University Constructs and methods for preparing circular rna
KR20230031756A (ko) * 2021-08-27 2023-03-07 한국과학기술원 신종 코로나바이러스 감염증 대응 예방 백신 조성물
AR127073A1 (es) 2021-09-17 2023-12-13 Flagship Pioneering Innovations Vi Llc Composiciones y métodos para producir polirribonucleótidos circulares
WO2023100159A2 (en) * 2021-12-03 2023-06-08 Kashiv Biosciences, Llc Multicistron expression vector for covid-19 vaccine
AU2022420620A1 (en) * 2021-12-23 2024-07-04 Flagship Pioneering Innovations Vi, Llc Circular polyribonucleotides encoding antifusogenic polypeptides
CN114249662B (zh) * 2021-12-27 2024-06-21 硅羿科技(上海)有限公司 一种药用脂质体辅料alc-0315的制备方法
WO2023126053A1 (en) * 2021-12-28 2023-07-06 BioNTech SE Lipid-based formulations for administration of rna
TW202334412A (zh) * 2022-01-11 2023-09-01 北京大學 針對 sars-cov-2 變體的環狀 rna 疫苗及其使用方法
WO2023133684A1 (en) * 2022-01-11 2023-07-20 Peking University Circular rna vaccines against sars-cov-2 variants and methods of use thereof
CN118574646A (zh) * 2022-01-19 2024-08-30 上海优替济生生物医药有限公司 环状rna及其用途
EP4466029A1 (en) * 2022-01-21 2024-11-27 Orna Therapeutics, Inc. Systemic administration of circular rna polynucleotides encoding muscle proteins or protein complexes
US20250235532A1 (en) * 2022-02-23 2025-07-24 Acm Biolabs Pte Ltd Polymer-lipid hybrid nanoparticles comprising a lipid and a block copolymer as well as methods of making and uses thereof
AU2023240827A1 (en) * 2022-03-21 2024-07-18 Bio Adventure Co., Ltd. Internal ribosome entry site (ires), plasmid vector and circular mrna for enhancing protein expression
CN115850104B (zh) * 2022-04-29 2023-07-18 北京剂泰医药科技有限公司 可电离脂质化合物
CN117529556A (zh) * 2022-05-20 2024-02-06 浙江健新原力制药有限公司 制备环状rna的方法
CN115074364B (zh) * 2022-06-25 2026-06-02 中国农业大学 环状RNA分子circRNA928及其编码基因与应用
CN119768517A (zh) * 2022-07-08 2025-04-04 上海环码生物医药有限公司 用于纯化环状核酸的方法和系统
TW202428289A (zh) 2022-11-08 2024-07-16 美商歐納醫療公司 環狀rna組合物
EP4634390A2 (en) 2022-12-15 2025-10-22 Orna Therapeutics, Inc. Circular rna compositions and methods
WO2024137392A1 (en) 2022-12-22 2024-06-27 Genscript Usa Inc. Method of preparing self-circularized rna
CN116411023B (zh) * 2023-02-24 2025-08-12 北京大学人民医院 一种新型环状rna成环序列构建car-t细胞及在治疗小细胞肺癌中的应用
EP4680276A1 (en) * 2023-03-15 2026-01-21 Flagship Pioneering Innovations VI, LLC Immunogenic compositions and uses thereof
EP4698150A1 (en) 2023-04-19 2026-02-25 Sail Biomedicines, Inc. Delivery of polynucleotides from lipid nanoparticles comprising rna and ionizable lipids
EP4702148A1 (en) * 2023-04-25 2026-03-04 Ginkgo Bioworks, Inc. Novel internal ribosome entry site (ires) and intron sequences
WO2024233308A2 (en) 2023-05-05 2024-11-14 Orna Therapeutics, Inc. Circular rna compositions and methods
EP4719352A1 (en) 2023-05-31 2026-04-08 Capstan Therapeutics, Inc. Lipid nanoparticle formulations and compositions
CN119015401B (zh) * 2023-06-21 2025-07-08 浙江大学 一种基于rna的肿瘤疫苗、制备方法、免疫佐剂及应用
CN119265241A (zh) 2023-06-30 2025-01-07 深圳菁童生命科学有限公司 一种无相分离转录因子介导启始阶段重编程使细胞年轻化的方法
WO2025007148A1 (en) 2023-06-30 2025-01-02 Orna Therapeutics, Inc. Polymer lipid nanoparticle compositions for delivering circular polynucleotides
CN121532514A (zh) * 2023-07-07 2026-02-13 上海环码生物医药有限公司 用于季节性流感的环状rna疫苗及使用方法
CN121986162A (zh) * 2023-07-07 2026-05-05 仁景(苏州)生物科技有限公司 制备环状rna方法及用于所述方法的核酸序列
KR20260042228A (ko) * 2023-07-24 2026-03-30 스트랜드 세러퓨틱스 인코포레이티드 체외 세포 요법을 위한 조작된 면역 세포를 생산하기 위한 rna 기반 합성 회로
CN116732039B (zh) * 2023-08-03 2023-11-14 呈诺再生医学科技(北京)有限公司 一种促进rna序列在细胞内直接环化翻译的序列组合及其应用
CN122270557A (zh) * 2023-08-17 2026-06-23 武汉大学 稳定性与表达量增强的环状rna
WO2025049690A1 (en) 2023-08-29 2025-03-06 Orna Therapeutics, Inc. Circular polyethylene glycol lipids
EP4771154A2 (en) 2023-09-01 2026-07-08 Renagade Therapeutics Management Inc. Gene editing systems, compositions, and methods for treatment of vexas syndrome
CN122497525A (zh) 2023-11-07 2026-07-31 欧纳医疗公司 环状rna组合物
CN117771264B (zh) * 2023-11-27 2024-06-25 山东省农业科学院畜牧兽医研究所 circHIF1α在制备抵御细菌感染的新型疫苗中的应用
WO2025117969A1 (en) 2023-12-01 2025-06-05 Orna Therapeutics, Inc. Process for manufacturing lipid nanoparticles
WO2025128871A2 (en) 2023-12-13 2025-06-19 Renagade Therapeutics Management Inc. Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
WO2025140249A1 (en) * 2023-12-26 2025-07-03 Suzhou Abogen Biosciences Co., Ltd. A circular rna and relevant constructs and a method using the same
CN120082543A (zh) * 2024-01-10 2025-06-03 上海环码生物医药有限公司 用于纯化环状核酸的阴选方法和系统
WO2025155753A2 (en) 2024-01-17 2025-07-24 Renagade Therapeutics Management Inc. Improved gene editing system, guides, and methods
WO2025179198A1 (en) * 2024-02-23 2025-08-28 Sail Biomedicines, Inc. Circular polyribonucleotides and unmodified linear rnas with reduced immunogenicity
CN118291452B (zh) * 2024-02-28 2025-03-14 山西高等创新研究院 一种基于i型内含子核酶体外制备环状rna的系统及其应用
CN120138000B (zh) * 2024-03-14 2026-01-13 广州国家实验室 一种用于制备环状rna的载体及其应用
WO2025222086A1 (en) * 2024-04-19 2025-10-23 Ginkgo Bioworks, Inc. Novel intron sequences for circularizing rna molecules
CN118127022B (zh) * 2024-04-30 2024-07-12 四川大学 变异链球菌环状RNA circcsbD及应用、其过表达菌株及构建方法和应用
WO2025250751A1 (en) 2024-05-31 2025-12-04 Orna Therapeutics, Inc. Circular rna compositions and methods
CN118813602B (zh) * 2024-06-21 2025-07-08 毕昇(北京)生物科技有限公司 基于尖孢镰刀菌CoB基因的I型内含子的构建体及其构建方法、RNA环化方法、环状RNA和应用
WO2026006644A1 (en) * 2024-06-26 2026-01-02 Emervax, Inc. Circular mrna yellow fever vaccine
WO2026003582A2 (en) 2024-06-27 2026-01-02 Axelyf ehf. Lipids and lipid nanoparticles
WO2026006593A1 (en) 2024-06-28 2026-01-02 Orna Therapeutics, Inc. Synthetic internal ribosome entry sites
WO2026046351A1 (en) * 2024-08-29 2026-03-05 Shanghai Circode Biomed Co., Ltd. Circular rna encoding vegf polypeptides, formulations, and methods of uses
WO2026072709A1 (en) 2024-09-25 2026-04-02 Orna Therapeutics, Inc. Chimeric antigen receptors targeting bcma
CN119326915A (zh) * 2024-10-18 2025-01-21 联健生物(苏州)有限公司 一种促进组织修复的纳米制剂及其应用
CN118995640A (zh) * 2024-10-21 2024-11-22 云南省肿瘤医院(昆明医科大学第三附属医院) 一种具有溶瘤作用的柯萨奇病毒b组5型毒株及其应用
WO2026096738A1 (en) 2024-10-31 2026-05-07 Orna Therapeutics, Inc. Chimeric antigen receptors targeting cd19
CN121991942A (zh) * 2024-11-07 2026-05-08 中国科学院杭州医学研究所 一种无疤痕环状核酸分子的制备方法及其在靶向递送中的应用
WO2026122418A1 (en) 2024-12-02 2026-06-11 Orna Therapeutics, Inc. Circular rna compositions and methods
WO2026122685A1 (en) 2024-12-03 2026-06-11 Orna Therapeutics, Inc. Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
WO2026165530A1 (en) 2025-02-03 2026-08-06 Renagade Therapeutics Management Inc. Hydrophilic polymer lipids for use in lipid nanoparticles
CN121838869A (zh) * 2025-12-03 2026-04-10 广州达安临床检验中心有限公司 基于snp突变频率相似度判断样本错配与污染的方法、装置、计算机设备

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3832253A (en) 1973-03-21 1974-08-27 Baxter Laboratories Inc Method of making an inflatable balloon catheter
US4450150A (en) 1973-05-17 1984-05-22 Arthur D. Little, Inc. Biodegradable, implantable drug delivery depots, and method for preparing and using the same
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4667014A (en) 1983-03-07 1987-05-19 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
CA1200416A (en) 1983-05-13 1986-02-11 Societe Des Produits Nestle S.A. Food process
US5019369A (en) 1984-10-22 1991-05-28 Vestar, Inc. Method of targeting tumors in humans
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4737323A (en) 1986-02-13 1988-04-12 Liposome Technology, Inc. Liposome extrusion method
IN165717B (cg-RX-API-DMAC7.html) 1986-08-07 1989-12-23 Battelle Memorial Institute
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
FR2645866B1 (fr) 1989-04-17 1991-07-05 Centre Nat Rech Scient Nouvelles lipopolyamines, leur preparation et leur emploi
JPH04167172A (ja) 1990-10-31 1992-06-15 Nec Corp ベクトルプロセッサ
US5334761A (en) 1992-08-28 1994-08-02 Life Technologies, Inc. Cationic lipids
US5885613A (en) 1994-09-30 1999-03-23 The University Of British Columbia Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
US5744335A (en) 1995-09-19 1998-04-28 Mirus Corporation Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
EP1027069B1 (en) 1997-10-29 2006-07-26 Genzyme Corporation Gene therapy for gaucher disease
US5948902A (en) 1997-11-20 1999-09-07 South Alabama Medical Science Foundation Antisense oligonucleotides to human serine/threonine protein phosphatase genes
EP1261379A2 (en) 2000-02-17 2002-12-04 Genzyme Corporation Genetic modification of the lung as a portal for gene delivery
AU2002368077B2 (en) 2001-07-12 2010-03-04 Jefferson Foote Super humanized antibodies
US20040014194A1 (en) 2002-03-27 2004-01-22 Schering Corporation Beta-secretase crystals and methods for preparing and using the same
CA2569664C (en) 2004-06-07 2013-07-16 Protiva Biotherapeutics, Inc. Lipid encapsulated interfering rna
WO2008103276A2 (en) 2007-02-16 2008-08-28 Merck & Co., Inc. Compositions and methods for potentiated activity of biologicaly active molecules
AU2009303345B2 (en) 2008-10-09 2015-08-20 Arbutus Biopharma Corporation Improved amino lipids and methods for the delivery of nucleic acids
WO2010053572A2 (en) 2008-11-07 2010-05-14 Massachusetts Institute Of Technology Aminoalcohol lipidoids and uses thereof
EP3391877A1 (en) 2010-04-08 2018-10-24 The Trustees of Princeton University Preparation of lipid nanoparticles
US9999673B2 (en) 2011-01-11 2018-06-19 Alnylam Pharmaceuticals, Inc. PEGylated lipids and their use for drug delivery
KR20220025112A (ko) 2011-06-08 2022-03-03 샤이어 휴먼 지네틱 테라피즈 인크. Mrna 전달을 위한 지질 나노입자 조성물 및 방법
EP4074693A1 (en) 2011-06-08 2022-10-19 Translate Bio, Inc. Cleavable lipids
EP2734184B1 (en) 2011-07-21 2018-03-28 Croda International Plc Branched polyether-polyamide block copolymers and methods of making and using the same
HRP20220070T1 (hr) * 2014-04-23 2022-04-01 Modernatx, Inc. Cjepiva nukleinske kiseline
AU2015289656A1 (en) * 2014-07-16 2017-02-16 Modernatx, Inc. Circular polynucleotides
HRP20220156T1 (hr) 2015-09-17 2022-04-15 Modernatx, Inc. Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
CN108368028B (zh) 2015-10-28 2021-09-03 爱康泰生治疗公司 用于递送核酸的新型脂质和脂质纳米颗粒制剂
WO2017222911A1 (en) * 2016-06-20 2017-12-28 The Board Of Trustees Of The Leland Stanford Junior University Circular rnas and their use in immunomodulation
CN110168090B (zh) * 2016-12-27 2023-07-18 国立大学法人东京大学 mRNA的功能化方法
MX2020006150A (es) * 2017-12-15 2020-11-11 Flagship Pioneering Innovations Vi Llc Composiciones que comprenden polirribonucleotidos circulares y usos de las mismas.
WO2019213308A1 (en) * 2018-05-01 2019-11-07 Fred Hutchinson Cancer Research Center Nanoparticles for gene expression and uses thereof
EP3826643A4 (en) * 2018-07-24 2022-05-18 Mayo Foundation for Medical Education and Research Circularized engineered rna and methods
JP2022552371A (ja) 2019-10-15 2022-12-15 モデルナティエックス インコーポレイテッド 免疫調節ポリペプチドをコードするmRNA及びその使用

Similar Documents

Publication Publication Date Title
US12318444B2 (en) Rotavirus vaccines
JP7803621B2 (ja) ヒトサイトメガロウイルスワクチン
AU2024200425B2 (en) Cancer vaccines
US12201682B2 (en) Henipavirus vaccine
US20260137769A1 (en) Nucleic acid molecules and uses thereof
US10543269B2 (en) hMPV RNA vaccines
JP2025041835A (ja) 呼吸器合胞体ウイルスワクチン
CN110381994B (zh) 用于诱导针对寨卡病毒的免疫应答的核苷修饰的rna
CA3041307A1 (en) Human cytomegalovirus vaccine
CN120379690A (zh) 基于核酸的通用疫苗和其使用方法
US20250099572A1 (en) Vaccine compositions
JP2025520111A (ja) Rnaアジュバント、その方法及び使用
KR20260066054A (ko) 동물 건강에 사용하기 위한 rna 백신
CN121604975A (zh) Rna疫苗
HK40109231A (zh) Rna分子
WO2024128201A1 (ja) mRNAワクチン
HK40125987A (en) Immunogenic compositions and methods of inducing an immune response against varicella zoster virus